AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25355774 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined antibacterial and fluoride therapy
Number of subjects: 109
Study 23916716 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiotherapy (RT) with cisplatin 20mg/m(2) chemotherapy on 5 consecutive days during weeks 1 and 5 or 6 of RT
Number of subjects: 136
Study 23916716 — intervention group
Group type: COMPARATOR
Intervention: Hyperfractionated radiotherapy (RT) without cisplatin
Number of subjects: 136
Study 23916716 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiotherapy (RT) with or without cisplatin
Number of subjects: 136
Study 23916716 — intervention group
Group type: EXPERIMENTAL
Intervention: Good response (CR/Cru)
Number of subjects: 136
Study 23916716 — intervention group
Group type: EXPERIMENTAL
Intervention: Good response at primary tumor and lymph nodes
Number of subjects: 136
Study 21823568 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable sutures
Number of subjects: 0
Study 21823568 — intervention group
Group type: COMPARATOR
Intervention: Non-absorbable sutures
Number of subjects: 0
Study 19349314 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta9‐Tetrahydrocannabinol (10 mg)
Number of subjects: 15
Study 19349314 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (600 mg)
Number of subjects: 15
Study 19349314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 16920653 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine inhaler
Number of subjects: 429
Study 16920653 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhaler
Number of subjects: 429
Study 16920653 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 429
Study 15232792 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dietary counseling
Number of subjects: 41
Study 15232792 — intervention group
Group type: COMPARATOR
Intervention: Special oral liquid nutritional supplement (Nepro)
Number of subjects: 41
Study 15540421 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MT) 7.5-10.0 mg/week
Number of subjects: 62
Study 15540421 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (P) ≥ 10 mg/day + Methotrexate (MT)
Number of subjects: 62
Study 15540421 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MT)
Number of subjects: 62
Study 15540421 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (P) + Methotrexate (MT)
Number of subjects: 62
Study 11137255 — intervention group
Group type: EXPERIMENTAL
Intervention: ISCOM vaccines
Number of subjects: 0
Study 11137255 — intervention group
Group type: COMPARATOR
Intervention: Conventional non‐adjuvanted inactivated split virion vaccine
Number of subjects: 0
Study 9143211 — intervention group
Group type: EXPERIMENTAL
Intervention: DHS questions
Number of subjects: 2352
Study 9143211 — intervention group
Group type: EXPERIMENTAL
Intervention: NSFG questions
Number of subjects: 2352
Study 9143211 — intervention group
Group type: EXPERIMENTAL
Intervention: Discordant responses to DHS and NSFG questions
Number of subjects: 2352
Study 9143211 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive factors
Number of subjects: 2352
Study 1606331 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 1 g/d
Number of subjects: 8
Study 1606331 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 2400 mg/d
Number of subjects: 8
Study 1606331 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 1 g/d and Cimetidine 2400 mg/d (combined therapy)
Number of subjects: 8
Study 1606331 — intervention group
Group type: COMPARATOR
Intervention: Drug-free
Number of subjects: 8
Study 3456797 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper removable appliance
Number of subjects: 22
Study 3456797 — intervention group
Group type: COMPARATOR
Intervention: Upper fixed appliance
Number of subjects: 22
Study 3456797 — intervention group
Group type: COMPARATOR
Intervention: Lower fixed appliance
Number of subjects: 22
Study 3041944 — intervention group
Group type: EXPERIMENTAL
Intervention: Apraclonidine 0.5%
Number of subjects: 20
Study 3041944 — intervention group
Group type: EXPERIMENTAL
Intervention: Apraclonidine 0.25%
Number of subjects: 20
Study 3041944 — intervention group
Group type: EXPERIMENTAL
Intervention: Apraclonidine 0.125%
Number of subjects: 20
Study 3041944 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 20
Study 3041944 — intervention group
Group type: EXPERIMENTAL
Intervention: All concentrations of apraclonidine
Number of subjects: 20
Study 3041944 — intervention group
Group type: EXPERIMENTAL
Intervention: Apraclonidine (all concentrations)
Number of subjects: 20
Study 31468059 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Number of subjects: 151
Study 31468059 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 151
Study 29469713 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based education
Number of subjects: 39
Study 29469713 — intervention group
Group type: COMPARATOR
Intervention: Verbal education
Number of subjects: 39
Study 25601762 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled glucocorticoids (multiple doses)
Number of subjects: 120
Study 25601762 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled data from three additional independent GWAS studies
Number of subjects: 120
Study 23284074 — intervention group
Group type: EXPERIMENTAL
Intervention: lactate-based low-GDP solution
Number of subjects: 60
Study 23284074 — intervention group
Group type: COMPARATOR
Intervention: lactate-based high-GDP solution
Number of subjects: 60
Study 21312255 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectra Optia
Number of subjects: 32
Study 21312255 — intervention group
Group type: COMPARATOR
Intervention: MCS+
Number of subjects: 32
Study 19602185 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercises for the calf muscles
Number of subjects: 3
Study 18057662 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcimimetics
Number of subjects: 0
Study 15780527 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) with estradiol 17‐valerate 2 mg for the first 11 days and estradiol 17‐valerate 2 mg plus ciproterone acetate 1 mg for the next 10 days, administered for 6 months
Number of subjects: 40
Study 15780527 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HRT)
Number of subjects: 40
Study 11517122 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous morphine (CM, 10 microg x kg(‐1) x h(‐1)) with three‐hourly placebo boluses
Number of subjects: 0
Study 11517122 — intervention group
Group type: COMPARATOR
Intervention: Intermittent morphine (IM, 30 microg x kg(‐1) every 3 h) with a placebo infusion
Number of subjects: 0
Study 11517122 — intervention group
Group type: COMPARATOR
Intervention: Preoperative plasma concentrations of norepinephrine
Number of subjects: 0
Study 11517122 — intervention group
Group type: COMPARATOR
Intervention: Preoperative plasma concentrations of lactate
Number of subjects: 0
Study 11517122 — intervention group
Group type: COMPARATOR
Intervention: Postoperative plasma concentrations of epinephrine
Number of subjects: 0
Study 11517122 — intervention group
Group type: COMPARATOR
Intervention: Postoperative plasma concentrations of insulin
Number of subjects: 0
Study 10197215 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (2 mg)
Number of subjects: 0
Study 10197215 — intervention group
Group type: EXPERIMENTAL
Intervention: Swallowed beclomethasone dipropionate (2 mg)
Number of subjects: 0
Study 10197215 — intervention group
Group type: COMPARATOR
Intervention: Metered dose inhaler with large volume spacer (2 mg beclomethasone dipropionate)
Number of subjects: 0
Study 7852620 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Dental Analgesia (EDA)
Number of subjects: 30
Study 7852620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 3391341 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeping medication alone
Number of subjects: 8
Study 3391341 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeping medication with 5.0 mg methscopolamine bromide
Number of subjects: 8
Study 3391341 — intervention group
Group type: COMPARATOR
Intervention: Control night (no methscopolamine)
Number of subjects: 8
Study 3391341 — intervention group
Group type: EXPERIMENTAL
Intervention: Methscopolamine administration
Number of subjects: 8
Study 31571853 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidafenacin 0.1 mg
Number of subjects: 27
Study 31571853 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidafenacin 0.2 mg
Number of subjects: 27
Study 31571853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 28781026 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Dose Statin + Armolipid Plus (n=50)
Number of subjects: 100
Study 28781026 — intervention group
Group type: COMPARATOR
Intervention: Low-Dose Statin (n=50)
Number of subjects: 100
Study 25658973 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructed extinction and removal of the shock electrode
Number of subjects: 0
Study 25658973 — intervention group
Group type: COMPARATOR
Intervention: Detailed description of the experimental scenario
Number of subjects: 0
Study 23446901 — intervention group
Group type: EXPERIMENTAL
Intervention: Caribbean starch dietary pattern
Number of subjects: 235
Study 23446901 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit and vegetables dietary pattern
Number of subjects: 235
Study 23446901 — intervention group
Group type: EXPERIMENTAL
Intervention: Pizza and sweets dietary pattern
Number of subjects: 235
Study 23446901 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat dietary pattern
Number of subjects: 235
Study 23446901 — intervention group
Group type: EXPERIMENTAL
Intervention: Fried food dietary pattern
Number of subjects: 235
Study 21216310 — intervention group
Group type: EXPERIMENTAL
Intervention: HIVIS DNA vaccine (arm B)
Number of subjects: 20
Study 21216310 — intervention group
Group type: COMPARATOR
Intervention: HAART (arm A)
Number of subjects: 20
Study 19638214 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training (8-week program based on Mindfulness-based Stress Reduction [MBSR])
Number of subjects: 87
Study 19638214 — intervention group
Group type: COMPARATOR
Intervention: Social-support group (attention-control condition)
Number of subjects: 87
Study 16626544 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBNP (1.5 microg/kg bolus intravenous injection followed by 0.0075 microg.kg(‐1).mn(‐1) for the first 3 hours and 0.015‐0.03 microg.kg(‐1).mn(‐1) infusion for following 21 hours)
Number of subjects: 42
Study 16626544 — intervention group
Group type: COMPARATOR
Intervention: NIT (10 to 100 microg/mn intravenous infusion for 24 hours)
Number of subjects: 42
Study 16626544 — intervention group
Group type: EXPERIMENTAL
Intervention: Total urine output
Number of subjects: 42
Study 16626544 — intervention group
Group type: EXPERIMENTAL
Intervention: Major adverse cardiac events (MACE)
Number of subjects: 42
Study 15380463 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm blood flow (FBF) during reactive hyperemia
Number of subjects: 110
Study 15380463 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum angiotensin-converting enzyme (ACE) activity
Number of subjects: 110
Study 15380463 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum concentrations of nitrite/nitrate
Number of subjects: 110
Study 11687453 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune milk (n = 4)
Number of subjects: 8
Study 11687453 — intervention group
Group type: COMPARATOR
Intervention: Nonimmune milk (Control group, n = 4)
Number of subjects: 8
Study 9644823 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit skill acquisition
Number of subjects: 0
Study 9644823 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit skill acquisition
Number of subjects: 0
Study 9644823 — intervention group
Group type: COMPARATOR
Intervention: Induced anxiety
Number of subjects: 0
Study 7943116 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol (1 to 2 mg hourly on request)
Number of subjects: 100
Study 7943116 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (50 to 100 micrograms hourly on request)
Number of subjects: 100
Study 7943116 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs (Butorphanol and Fentanyl)
Number of subjects: 100
Study 3605567 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.15 mg/kg
Number of subjects: 50
Study 3605567 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 0.25 mg/kg
Number of subjects: 50
Study 31397770 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient Cardiac Rehabilitation (OCR), 20 sessions
Number of subjects: 104
Study 31397770 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 104
Study 28544222 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR-based sequencing to detect clarithromycin resistance-associated mutations using fecal samples
Number of subjects: 0
Study 28544222 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA of isolated strains
Number of subjects: 0
Study 28544222 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy including clarithromycin
Number of subjects: 0
Study 24973894 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen at 80 mg/day
Number of subjects: 30
Study 24973894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 23608190 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening Checklist for Auditory Processing (SCAP)
Number of subjects: 400
Study 23608190 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening Test for Auditory Processing (STAP)
Number of subjects: 400
Study 23608190 — intervention group
Group type: COMPARATOR
Intervention: Comparison of SCAP and STAP
Number of subjects: 400
Study 23608190 — intervention group
Group type: COMPARATOR
Intervention: SCAP and auditory memory subsection of STAP
Number of subjects: 400
Study 21318566 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (100 mg oral)
Number of subjects: 52
Study 21318566 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine (0.42 mg/kg oral)
Number of subjects: 52
Study 21318566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 19403636 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary Modification intervention (n = 19,541; daily goal: < or =20% of energy as fat, > or =5 servings of vegetables and fruit, and > or =6 servings of grains)
Number of subjects: 48835
Study 19403636 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary Modification intervention (n = 19,541)
Number of subjects: 48835
Study 19403636 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (n = 29,294; no dietary changes)
Number of subjects: 48835
Study 19403636 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (n = 29,294)
Number of subjects: 48835
Study 19403636 — intervention group
Group type: EXPERIMENTAL
Intervention: Subset of women (n = 3951)
Number of subjects: 48835
Study 17435550 — intervention group
Group type: EXPERIMENTAL
Intervention: High- or moderate-volume center with D1 or D2 dissection
Number of subjects: 448
Study 17435550 — intervention group
Group type: COMPARATOR
Intervention: Low-volume hospital with D1 or D2 dissection
Number of subjects: 448
Study 17435550 — intervention group
Group type: EXPERIMENTAL
Intervention: D0 resection
Number of subjects: 448
Study 15118464 — intervention group
Group type: EXPERIMENTAL
Intervention: dorzolamide + timolol
Number of subjects: 30
Study 15118464 — intervention group
Group type: EXPERIMENTAL
Intervention: dorzolamide + acetazolamide
Number of subjects: 30
Study 15118464 — intervention group
Group type: EXPERIMENTAL
Intervention: acetazolamide
Number of subjects: 30
Study 15118464 — intervention group
Group type: EXPERIMENTAL
Intervention: timolol
Number of subjects: 30
Study 15118464 — intervention group
Group type: EXPERIMENTAL
Intervention: dorzolamide
Number of subjects: 30
Study 15118464 — intervention group
Group type: COMPARATOR
Intervention: vehicle alone
Number of subjects: 30
Study 11298623 — intervention group
Group type: COMPARATOR
Intervention: trk C immunoreactive neurones in control infant colon
Number of subjects: 16
Study 11298623 — intervention group
Group type: EXPERIMENTAL
Intervention: trk C immunoreactive neurones in normoganglionic Hirschsprung's disease
Number of subjects: 16
Study 11298623 — intervention group
Group type: EXPERIMENTAL
Intervention: trk C immunoreactive neurones in STC
Number of subjects: 16
Study 11298623 — intervention group
Group type: EXPERIMENTAL
Intervention: Sural nerve abnormalities in STC
Number of subjects: 16
Study 10592815 — intervention group
Group type: EXPERIMENTAL
Intervention: TETRAMUNE (HibTITER with whole‐cell DTP)
Number of subjects: 90
Study 10592815 — intervention group
Group type: COMPARATOR
Intervention: DTP and HibTITER administered concurrently
Number of subjects: 90
Study 8200716 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 10
Study 3067834 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 30
Study 3067834 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 30
Study 30031454 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted lifestyle intervention (7 group sessions including a cooking class)
Number of subjects: 96
Study 30031454 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96
Study 27193768 — intervention group
Group type: EXPERIMENTAL
Intervention: Capacity Enhancement (CE) intervention
Number of subjects: 31
Study 27193768 — intervention group
Group type: COMPARATOR
Intervention: Standard Dissemination (SD) condition
Number of subjects: 31
Study 23871120 — intervention group
Group type: EXPERIMENTAL
Intervention: Errorless learning (ELL) and spaced retrieval (SR) cognitive techniques, trained twice a week for 4 weeks
Number of subjects: 20
Study 23871120 — intervention group
Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 20
Study 22336574 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine infusion
Number of subjects: 10
Study 22336574 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone infusion
Number of subjects: 10
Study 22336574 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 10
Study 22336574 — intervention group
Group type: COMPARATOR
Intervention: Placebo for hydrocortisone
Number of subjects: 10
Study 20375291 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 hours of supplemental reading intervention
Number of subjects: 30
Study 20375291 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 30
Study 18297478 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff education
Number of subjects: 52
Study 18297478 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support
Number of subjects: 52
Study 18297478 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 18297478 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff education and peer support
Number of subjects: 52
Study 15797165 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression-based prediction formulas for RBANS subtests
Number of subjects: 223
Study 11914101 — intervention group
Group type: EXPERIMENTAL
Intervention: l-NMMA (3 mg.h(‐1).kg(‐1))
Number of subjects: 24
Study 11914101 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine (12‐36 microg.h(‐1).kg(‐1))
Number of subjects: 24
Study 11914101 — intervention group
Group type: COMPARATOR
Intervention: Nitrate+nitrite levels in plasma
Number of subjects: 24
Study 10695206 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasopharyngeal airway insertion by trained nurses
Number of subjects: 212
Study 10695206 — intervention group
Group type: COMPARATOR
Intervention: Nasopharyngeal airway insertion by anesthesiologists
Number of subjects: 212
Study 8561215 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 43
Study 8561215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 1414897 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposorber LA-15 System (LDL apheresis)
Number of subjects: 64
Study 1414897 — intervention group
Group type: COMPARATOR
Intervention: Control (standard diet and drug therapy)
Number of subjects: 64
Study 4064517 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydration
Number of subjects: 100
Study 4064517 — intervention group
Group type: COMPARATOR
Intervention: Normal hydration
Number of subjects: 100
Study 31176289 — intervention group
Group type: EXPERIMENTAL
Intervention: Impella CP transvalvular microaxial flow pump
Number of subjects: 100
Study 31176289 — intervention group
Group type: COMPARATOR
Intervention: Current guideline-driven therapy
Number of subjects: 100
Study 29258695 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT)
Number of subjects: 480
Study 29258695 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CCRT) alone
Number of subjects: 480
Study 24485882 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with spastic cerebral palsy
Number of subjects: 25
Study 24485882 — intervention group
Group type: COMPARATOR
Intervention: Typically developing controls
Number of subjects: 25
Study 23469629 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment for HCV (Pegylated interferon and Ribavirin)
Number of subjects: 80
Study 23469629 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus Fluvastatin (80 mg/daily)
Number of subjects: 80
Study 20167584 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% for Group A (BMI >27 kg/m²)
Number of subjects: 21
Study 20167584 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% for Group B (BMI 24-27 kg/m²)
Number of subjects: 21
Study 20167584 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% for Group C (BMI <24 kg/m²)
Number of subjects: 21
Study 20167584 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Group A vs Group C
Number of subjects: 21
Study 17414745 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 34
Study 17414745 — intervention group
Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 34
Study 15816887 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir prophylaxis
Number of subjects: 352
Study 15816887 — intervention group
Group type: COMPARATOR
Intervention: Valganciclovir prophylaxis
Number of subjects: 352
Study 11934908 — intervention group
Group type: EXPERIMENTAL
Intervention: Dowsing with Bryonia 12c potency
Number of subjects: 156